Coalition for Better Health
Independent research for informed health decisions
This month's focus
GLP-1 Receptor Agonists: Separating Evidence from Hype
Our latest position paper examines the clinical trial data behind GLP-1 therapeutics, long-term metabolic outcomes, and what the evidence actually supports for Australian patients.
Read the research →Featured Research
Featured Research
The Future of Weight Management: From Lifestyle to Pharmacotherapy
An evidence-based overview of the evolution of obesity treatment — from lifestyle intervention through bariatric surgery to next-generation pharmacotherapy — and what research suggests about long-term metabolic health management.
Our Mission
CoalitionForBetterHealth.org is an independent platform dedicated to evidence-based health research, metabolic science, and informed healthcare decisions.
Recent Articles
View all →Childhood Obesity in Australia: Why Individual Responsibility Framing Has Failed and What Policy Must Change
One in four Australian children is overweight or obese. A policy analysis of why 'eat less, move more' campaigns fail, and what evidence-based interventions — sugar taxes, advertising bans, food labelling reform, and school food environments — can actually work.
Rural and Remote Health Access in Australia: The Policy Gap That's Costing Lives
Rural Australians die on average two years younger than their city counterparts. A policy analysis of the GP workforce crisis, specialist access deserts, the MBS telehealth permanency debate, RFDS funding constraints, and the concrete reforms needed to close the gap.
Antimicrobial Resistance in Australia: Stewardship, Surveillance, and the Path Through 2030
How Australia's National AMR Strategy 2020-2030, AURA surveillance data, persistent primary care over-prescribing for URTIs and dental indications, APVMA oversight of animal-use antibiotics, WHO AWaRe adoption, and a stalled global pipeline are reshaping antimicrobial stewardship policy.
My Health Record and Digital Health Interoperability: Australia's Reform Pathway
An analysis of Australia's My Health Record opt-out model, FHIR adoption and Sharing by Default reforms, primary care upload reliability, hospital integration gaps, and the consumer-trust hangover from the Medibank and Optus breaches shaping policy debate.
Pharmaceutical Price Disclosure in Australia: How the PBS Cost Reduction Mechanism Works
Australia's price disclosure regime requires pharmaceutical manufacturers to disclose actual transaction prices, triggering mandatory PBS price reductions. A policy analysis of how the mechanism works, its impact on medicine affordability, and reform priorities.
TGA Reform Priorities for 2027: Accelerating Access to Medicines for Australians
Australia's Therapeutic Goods Administration faces mounting pressure to modernise its approval pathways, expand biosimilar uptake, close the digital therapeutics regulatory gap, and strengthen post-market surveillance. A policy analysis of the reform agenda for 2027.